An Updated Overview of Low Back Pain Management in Primary Care
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Jae-Young | - |
dc.contributor.author | Song, Kwang-Sup | - |
dc.contributor.author | Cho, Jae Hwan | - |
dc.contributor.author | Lee, Jae Hyup | - |
dc.date.accessioned | 2021-09-03T03:16:19Z | - |
dc.date.available | 2021-09-03T03:16:19Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-08 | - |
dc.identifier.issn | 1976-1902 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/82621 | - |
dc.description.abstract | Currently, guidelines for lower back pain (LBP) treatment are needed. We reviewed the current guidelines and high-quality articles to confirm the LBP guidelines for the Korean Society of Spine Surgery. We searched available databases for high-quality articles in English on LBP published from 2000 to the present year. Literature searches using these guidelines included studies from MEDLINE, the Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials, and Embase. We analyzed a total of 132 randomized clinical trials, 116 systematic reviews, 9 meta-analyses, and 4 clinical guideline reviews. We adopted the SIGN checklist for the assessment of article quality. Data were subsequently abstracted by a reviewer and verified. Many treatment options exist for LBP, with a variety of recommendation grades. We assessed the recommendation grade for general behavior, pharmacological therapy, psychological therapy, and specific exercises. This information should be helpful to physicians in the treatment of LBP patients. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC SPINE SURGERY | - |
dc.subject | RANDOMIZED CONTROLLED-TRIAL | - |
dc.subject | BUPRENORPHINE TRANSDERMAL SYSTEM | - |
dc.subject | OXYMORPHONE EXTENDED-RELEASE | - |
dc.subject | SPINAL MANIPULATIVE THERAPY | - |
dc.subject | CLINICAL-PRACTICE GUIDELINE | - |
dc.subject | OPIOID-EXPERIENCED PATIENTS | - |
dc.subject | PLACEBO-CONTROLLED TRIAL | - |
dc.subject | CONTROLLED PHASE-III | - |
dc.subject | QUALITY-OF-LIFE | - |
dc.subject | DOUBLE-BLIND | - |
dc.title | An Updated Overview of Low Back Pain Management in Primary Care | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hong, Jae-Young | - |
dc.identifier.doi | 10.4184/asj.2017.11.4.653 | - |
dc.identifier.scopusid | 2-s2.0-85028363111 | - |
dc.identifier.wosid | 000411038700019 | - |
dc.identifier.bibliographicCitation | ASIAN SPINE JOURNAL, v.11, no.4, pp.653 - 660 | - |
dc.relation.isPartOf | ASIAN SPINE JOURNAL | - |
dc.citation.title | ASIAN SPINE JOURNAL | - |
dc.citation.volume | 11 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 653 | - |
dc.citation.endPage | 660 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Orthopedics | - |
dc.relation.journalWebOfScienceCategory | Orthopedics | - |
dc.subject.keywordPlus | RANDOMIZED CONTROLLED-TRIAL | - |
dc.subject.keywordPlus | BUPRENORPHINE TRANSDERMAL SYSTEM | - |
dc.subject.keywordPlus | OXYMORPHONE EXTENDED-RELEASE | - |
dc.subject.keywordPlus | SPINAL MANIPULATIVE THERAPY | - |
dc.subject.keywordPlus | CLINICAL-PRACTICE GUIDELINE | - |
dc.subject.keywordPlus | OPIOID-EXPERIENCED PATIENTS | - |
dc.subject.keywordPlus | PLACEBO-CONTROLLED TRIAL | - |
dc.subject.keywordPlus | CONTROLLED PHASE-III | - |
dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordAuthor | Lower back pain | - |
dc.subject.keywordAuthor | Treatment guideline | - |
dc.subject.keywordAuthor | Recommendation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.